Abstract:Heparin-induced thrombocytopenia (HIT) is an autoimmune disorder caused by antibodies against platelet factor 4 (PF4) and heparin complexes. Rapid immunoassays (IAs) for detection of these antibodies mark a milestone in HIT diagnosis, despite a higher false-positive rate compared with functional platelet-activation assays. However, combining different rapid IAs may help to improve their diagnostic specificity. Here, we compared the individual performance of the latex immunoturbidimetric assay (LIA; HemosIL HIT-Ab [PF4-H]; sensitivity 91.7%, specificity 68.4%) and chemiluminescence immunoassay (CLIA; HemosIL AcuStarHIT-Ab [PF4-H]; sensitivity 92.4%, specificity 85.8%) with their combined performance using two unique diagnostic algorithms in a single prospective cohort of suspected HIT patients. Using the simultaneous algorithm adapted from Warkentin et al, the combined LIA–CLIA had a sensitivity of 99.0% and specificity of 64.3%. The sequential algorithm adapted from Rittener-Ruff et al was applied in two theoretical scenarios to reflect real-world circumstances in diagnostic laboratories where access to clinical information is limited: (1) assuming all patients had an intermediate 4Ts score and (2) assuming all patients had a high 4Ts score. This algorithm correctly predicted HIT in 94.5% (high 4Ts) and 96.0% (intermediate 4Ts) and excluded HIT in 82.6% (high 4Ts) and 80.1% (intermediate 4Ts) of patients in either scenario, respectively. Although both combined algorithms improved diagnostic performance of individual IAs, the simultaneous algorithm showed fewer false predictions (7.9%) than the sequential algorithm (intermediate 4Ts: 37.6% and high 4Ts: 41.5%) and proved more practical as it does not rely on physician evaluations. Our findings highlight the importance of accounting for clinician and interlaboratory variability when evaluating diagnostic tests for HIT. A.B. and Y.Z. analyzed and interpreted the data, performed statistical analysis, and wrote the manuscript. M.C. performed statistical analysis and wrote the manuscript. J.C.M collected patient samples, performed experiments, and provided technical assistance. T.E.W. and D.M.A. interpreted data and wrote the manuscript. I.N. designed the research, analyzed and interpreted data, and wrote the manuscript. All authors reviewed and approved the final version of the manuscript. Article published online: 11 May 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Breast cancer cell-based ELISA: A potential material for better detection of heparin-induced thrombocytopenia antibodies

Use of a whole-cell ELISA to detect additional antibodies in setting of suspected heparin-induced thrombocytopenia

High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin-induced thrombocytopenia antibodies

Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia

Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays

Prospective evaluation of two specific IgG immunoassays (HemosIL® AcuStar HIT-IgG and HAT45G® ) for the diagnosis of heparin-induced thrombocytopenia: A Bayesian approach

A Functional Assay for the Determination of Heparin-Induced Thrombocytopenia via Flow Cytometry

Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia

Evaluating heparin-induced thrombocytopenia: the old and the new

Functional Testing for Heparin-Induced Thrombocytopenia Using Whole Blood Multiplate Impedance Aggregometry

Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia

Evaluation of a flow cytometric assay for the confirmation of heparin-induced thrombocytopenia

New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia

A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia

Evaluation of two new automated chemiluminescent assays (HemosIL® AcuStar HIT-IgG and HemosIL® AcuStar HIT-Ab) for the detection of heparin-induced antibodies in the diagnosis of heparin-induced thrombocytopenia

The use of flow cytometry in the diagnosis of heparin-induced thrombocytopenia (HIT)

Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT)

Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital

Absolute Immature Platelet Counts in the Setting of Suspected Heparin-Induced Thrombocytopenia May Predict Anti-Pf4-heparin Immunoassay Testing Results

Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies

Heparin-induced thrombocytopenia: detection of antiheparin/PF4 antibodies by means of heparin/PF4-coated beads and flow cytometry